GLA-funded Lyme disease research uses CRP biomarkers and VlsE antibodies to differentiate PTLDS patients from other Lyme patients.
https://globallymealliance.org/news/can-biomarkers-be-used-to-diagnose-stages-of-lyme-disease/?utm_source=Newsletter&utm_campaign=7676cae202-newsletter_201901&utm_medium=email&utm_term=0_2eb359dd6a-7676cae202-37072147&mc_cid=7676cae202&mc_eid=bdc005f938
No comments:
Post a Comment
Please be constructive in your comments.